Determinants of zinc transport in humans: Zinc status, exercise, inflammation and chronic diseases

Human Health and Nutrition: New Research

Volumn , Issue , 2015, Pages 17-48

  Chu, Anna ^a   Foster, Meika ^a   Samman, Samir ^a,b  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Cardiovascular disease; Diabetes mellitus; Exercise; Inflammation; Zinc

Indexed keywords

EID: 84957402747     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (168)

1. Prasad A. S., Miale A., Farid Z., Sandstead H. H., Schulert A. R. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypognadism. J. Lab. Clin. Med., 1963; 61: 537-49.
2. Andreini C., Banci L., Bertini I., Rosato A. Counting the zinc-proteins encoded in the human genome. J. Proteome Res., 2006; 5: 196-201.
3. Klug A. The discovery of zinc fingers and their applications in gene regulation and genome manipulation. Annu. Rev. Biochem., 2010; 79: 213-31.
4. Choi S., Bird A. J. Zinc'ing sensibly: controlling zinc homeostasis at the transcriptional level. Metallomics, 2014; 6: 1198-215.
5. Laity J. H., Lee B. M., Wright P. E. Zinc finger proteins: new insights into structural and functional diversity. Curr. Opin. Struct. Biol., 2001; 11: 39-46.
6. Vallee B. L., Falchuk K. H. The biochemical basis of zinc physiology. Physiol. Rev., 1993; 73: 79-118.
7. Samman S. Zinc. In: Mann J., Truswell A. S., editors. Essentials of Human Nutrition. 4th ed. Oxford: Oxford University Press; 2012. p. 171-5.
8. Wilson M., Hogstrand C., Maret W. Picomolar concentrations of free zinc(II) ions regulate receptor protein-tyrosine phosphatase ß activity. J. Biol. Chem., 2012; 287: 9322-6.
9. Foster M., Samman S. Zinc and redox signaling: perturbations associated with cardiovascular disease and diabetes mellitus. Antioxid. Redox. Signal, 2010; 13: 1549-73.
10. Fischer Walker C. L., Ezzati M., Black R. E. Global and regional child mortality and burden of disease attributable to zinc deficiency. Eur. J. Clin. Nutr., 2009; 63: 591-7.
11. Jansen J., Karges W., Rink L. Zinc and diabetes -clinical links and molecular mechanisms. J. Nutr. Biochem., 2009; 20: 399-417.
12. Little P. J., Bhattacharya R., Moreyra A. E., Korichneva I. L. Zinc and cardiovascular disease. Nutrition, 2010; 26: 1050-7.
13. King J. C. Does zinc absorption reflect zinc status? Int. J. Vitam. Nutr. Res., 2010; 80: 300-6.
14. Holt R. R., Uriu-adams J. Y., Keen C. L. Zinc. In: Erdman Jr. J. W., MacDonald I. A., Zeisel S. H., editors. Present Knowledge in Nutrition. 10th ed. London: Wiley-Blackwell, 2012. p. 521-39.
15. Chung C., Stookey J., Dare D. Current dietary zinc intake has a greater effect on fractional zinc absorption than does longer term zinc consumption in healthy adult men. Am. J. Clin. Nutr., 2008; 87: 1224-9.
16. Sandström B. Bioavailability of zinc. Eur. J. Clin. Nutr., 1997; 51: S17-9.
17. Bel-Serrat S., Stammers A.-L., Warthon-Medina M., Moran V. H., Iglesia-Altaba I., Hermoso M., Moreno L. A., Lowe N. M. Factors that affect zinc bioavailability and losses in adult and elderly populations. Nutr. Rev., 2014; 44: 1-19.
18. Foster M., Karra M., Picone T., Chu A., Hancock D. P., Petocz P., Samman S. Dietary fiber intake increases the risk of zinc deficiency in healthy and diabetic women. Biol. Trace Elem. Res., 2012; 149: 135-42.
19. Zaman K., McArthur J. O., Abboud M. N., Ahmad Z. I., Garg M. L., Petocz P., Samman S. Iron supplementation decreases plasma zinc but has no effect on plasma fatty acids in non-anemic women. Nutr. Res., 2013; 33: 272-8.
20. Schölmerich J., Freudemann A. Bioavailability of zinc from zinc-histidine complexes. I. Comparison with zinc sulfate in healthy men. Am. J. Clin. Nutr., 1987; 45:1480-6.
21. Samman S. Zinc. Nutr. Diet, 2007; 64: S131-4.
22. Wessells K. R., Singh G. M., Brown K. H. Estimating the Global Prevalence of Inadequate Zinc Intake from National Food Balance Sheets: Effects of Methodological Assumptions. PLoS One, 2012; 7: e50565.
23. World Health Organization. Trace elements in human nutrition and health. 1996.
24. Brown K. H., Rivera J. A., Bhutta Z., Gibson R. S., King J. C., Lönnerdal B., Ruel M. T., Sandtröm B., Wasantwisut E., et al. International Zinc Nutrition Consultative Group (IZiNCG) technical document #1. Assessment of the risk of zinc deficiency in populations and options for its control. Food Nutr. Bull., 2004; 25: S94-203.
25. Krebs N. E., Hambidge K. M. Zinc metabolism and homeostasis: the application of tracer techniques to human zinc physiology. Biometals, 2001; 14: 397-412.
26. Sian L., Mingyan X., Miller L. V., Tong L., Krebs N. F., Hambidge K. M. Zinc absorption and intestinal losses of endogenous zinc in young Chinese women with marginal zinc intakes. Am. J. Clin. Nutr., 1996; 63: 348-53.
27. Verus A. P., Samman S. Urinary zinc as a marker of zinc intake: results of a supplementation trial in free-living men. Eur. J. Clin. Nutr., 1994; 48: 219-21.
28. Thompson R. Assessment of zinc status. Proc. Nutr. Soc., 1991; 50: 19-28.
29. Jackson M. Physiology of zinc: general aspects. In: Mills C., editor. Zinc in Human Biology. New York, NY: Springer-Verlag; 1989. p. 1-14.
30. Smith K. T., Failla M. L., Cousins R. J. Identification of albumin as the plasma carrier for zinc absorption by perfused rat intestine. Biochem. J., 1979; 184: 627-33.
31. Lu J., Stewart A. J., Sadler P. J., Pinheiro T. J. T., Blindauer C. A. Albumin as a zinc carrier: properties of its high-affinity zinc-binding site. Biochem. Soc. Trans., 2008; 36: 1317-21.
32. Tibaduiza E. C., Bobilya D. J. Zinc transport across an endothelium includes vesicular cotransport with albumin. J. Cell Physiol., 1996; 167: 539-47.
33. King J. C., Shames D. M., Woodhouse L. R. Zinc homeostasis in humans. J. Nutr., 2000; 130: 1360S-6S.
34. Miller L. V., Hambidge K. M., Naake V. L., Hong Z., Westcott J. L., Fennessey P. V. Size of the zinc pools that exchange rapidly with plasma zinc in humans: alternative techniques for measuring and relation to dietary zinc intake. J. Nutr., 1994; 124: 268-76.
35. Overgaard K., Lindstrøm T., Ingemann-Hansen T., Clausen T. Membrane leakage and increased content of Na+ -K+ pumps and Ca2+ in human muscle after a 100-km run. J. Appl. Physiol., 2002; 92: 1891-8.
36. Clarkson P. M., Hubal M. J. Exercise-induced muscle damage in humans. Am. J. Phys. Med. Rehabil., 2002; 81: S52-69.
37. Lichten L. A., Cousins R. J. Mammalian zinc transporters: nutritional and physiologic regulation. Annu. Rev. Nutr., 2009; 29: 153-76.
38. Lowe N., Fekete K., Decsi T. Methods of assessment of zinc status in humans: a systematic review. Am. J. Clin. Nutr., 2009; 89: 2040-51.
39. International Zinc Nutrition Consultative Group. IZiNCG Technical Brief 2: Assessing population zinc status with serum zinc concentration. 2007.
40. Lowe N. M., Medina M. W., Stammers A.-L., Patel S., Souverein O. W., Dullemeijer C., Serra-Majem L., Nissensohn M., Moran V. H. The relationship between zinc intake and serum/plasma zinc concentration in adults: a systematic review and dose-response meta-analysis by the EURRECA network. Br. J. Nutr., 2012; 108: 1962-71.
41. Samman S. Challenges and opportunities in the assessment of zinc status. Nutr. Diet., 2011; 68: 95-6.
42. Foster M., Samman S. Zinc and regulation of inflammatory cytokines: implications for cardiometabolic disease. Nutrients, 2012; 4: 676-94.
43. Lowe N. M., Woodhouse L. R., Sutherland B., Shames D. M., Burri B. J., Abrams S. A., Turnlund J. R., Jackson M. J., King J. C. Kinetic parameters and plasma zinc concentration correlate well with net loss and gain of zinc from men. J. Nutr., 2004; 134: 2178-81.
44. Johnson P. E., Hunt C. D., Milne D. B., Mullen L. K. Homeostatic control of zinc metabolism in men: Zinc excretion and balance in men fed diets low in zinc. Am. J. Clin. Nutr., 1993; 57: 557-65.
45. National Health and Medical Research Council. Nutrient reference values for Australia and New Zealand: including recommended dietary intakes. Canberra, Australia: Commonwealth of Australia; 2006.
46. Hughes S., Samman S. The effect of zinc supplementation in humans on plasma lipids, antioxidant status and thrombogenesis. J. Am. Coll. Nutr., 2006; 25: 285-91.
47. Moore J. B., Blanchard R. K., Cousins R. J. Dietary zinc modulates gene expression in murine thymus: results from a comprehensive differential display screening. Proc. Natl. Acad. Sci. U S A, 2003; 100: 3883-8.
48. Beattie J. H., Gordon M.-J., Rucklidge G. J., Reid M. D., Duncan G. J., Horgan G. W., Cho Y.-E., Kwun I.-S. Aorta protein networks in marginal and acute zinc deficiency. Proteomics, 2008; 8: 2126-35.
49. Ryu M., Langkamp-Henken B., Chang S.-M., Shankar M. N., Cousins R. J. Genomic analysis, cytokine expression, and microRNA profiling reveal biomarkers of human dietary zinc depletion and homeostasis. Proc. Natl. Acad. Sci. U S A, 2011; 108: 20970-5.
50. Overbeck S., Uciechowski P., Ackland M. L., Ford D., Rink L. Intracellular zinc homeostasis in leukocyte subsets is regulated by different expression of zinc exporters ZnT-1 to ZnT-9. J. Leukoc. Biol., 2008; 83: 368-80.
51. Andree K., Kim J., Kirschke C. Investigation of lymphocyte gene expression for use as biomarkers for zinc status in humans. J. Nutr., 2004; 134: 1716-23.
52. Afman L., Milenkovic D., Roche H. M. Nutritional aspects of metabolic inflammation in relation to health-insights from transcriptomic biomarkers in PBMC of fatty acids and polyphenols. Mol. Nutr. Food Res., 2014; 58: 1708-20.
53. Powell E. E., Kroon P. A. Low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase gene expression in human mononuclear leukocytes is regulated coordinately and parallels gene expression in human liver. J. Clin. Invest., 1994; 93: 2168-74.
54. Rudkowska I., Raymond C., Ponton A., Jacques H., Lavigne C., Holub B. J., Marette A., Vohl M.-C. Validation of the use of peripheral blood mononuclear cells as surrogate model for skeletal muscle tissue in nutrigenomic studies. OMICS, 2011; 15: 1-7.
55. Golan Y., Berman B., Assaraf Y. G. Heterodimerization, Altered Subcellular Localization and Function of Multiple Zinc Transporters in Viable Cells Using Bimolecular Fluorescence Complementation. J. Biol. Chem., 2015; 290: 9050-63.
56. Lu M., Fu D. Structure of the zinc transporter YiiP. Science, 2007; 317: 1746-8.
57. Hogstrand C., Fu D. Zinc. In: Maret W., Wedd A., editors. Binding, Transport and Storage of Metal Ions in Biological Cells. Cambridge: Royal Society of Chemistry; 2014. p. 666-94.
58. Kelleher S. L., McCormick N. H., Velasquez V., Lopez V. Zinc in specialized secretory tissues: roles in the pancreas, prostate, and mammary gland. Adv. Nutr., 2011; 2: 101-11.
59. Qian L., Lopez V., Seo Y. A., Kelleher S. L. Prolactin regulates ZNT2 expression through the JAK2/STAT5 signaling pathway in mammary cells. Am. J. Physiol. Cell Physiol., 2009; 297: C369-77.
60. Lopez V., Kelleher S. L. Zinc transporter-2 (ZnT2) variants are localized to distinct subcellular compartments and functionally transport zinc. Biochem. J., 2009; 422: 43-52.
61. Jeong J., Eide D. J. The SLC39 family of zinc transporters. Mol. Aspects Med., 2013; 34: 612-9.
62. Gaither L. A., Eide D. J. Functional expression of the human hZIP2 zinc transporter. J. Biol. Chem., 2000; 275: 5560-4.
63. Girijashanker K., He L., Soleimani M., Reed J. M., Li H., Liu Z., Wang B., Dalton T. P., Nebert D. W. Slc39a14 gene encodes ZIP14, a metal/bicarbonate symporter: similarities to the ZIP8 transporter. Mol. Pharmacol., 2008; 73: 1413-23.
64. Jenkitkasemwong S., Wang C.-Y., Mackenzie B., Knutson M. D. Physiologic implications of metal-ion transport by ZIP14 and ZIP8. Biometals, 2012; 25: 643-55.
65. Hennigar S. R., Kelleher S. L. Zinc networks: the cell-specific compartmentalization of zinc for specialized functions. Biol. Chem., 2012; 393: 565-78.
66. Günther V., Lindert U., Schaffner W. The taste of heavy metals: gene regulation by MTF-1. Biochim. Biophys. Acta, 2012; 1823: 1416-25.
67. Ogo O. A., Tyson J., Cockell S. J., Howard A., Valentine R. A., Ford D. The zinc finger protein ZNF658 regulates the transcription of genes involved in zinc homeostasis and affects ribosome biogenesis through the zinc transcriptional regulatory element (ZTRE). Mol. Cell Biol., 2015; 35: 977-87.
68. Kambe T. Introduction: "Zinc Signaling"-The Blossoming Field of Zinc Biology. In: Fukada T., Kambe T., editors. Zinc Signals in Cellular Functions and Disorders. Toyko: Springer; 2014. p. 1-6.
69. Taylor K. M., Hiscox S., Nicholson R. I., Hogstrand C., Kille P. Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7. Sci. Signal, 2012; 5: ra11.
70. Wang C.-Y., Jenkitkasemwong S., Duarte S., Sparkman B. K., Shawki A., Mackenzie B., Knutson M. D. ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading. J. Biol. Chem., 2012; 287: 34032-43.
71. Bouron A., Oberwinkler J. Contribution of calcium-conducting channels to the transport of zinc ions. Pflugers Arch., 2014; 466: 381-7.
72. Colvin R. A., Davis N., Nipper R. W., Carter P. A. Zinc transport in the brain: routes of zinc influx and efflux in neurons. J. Nutr., 2000; 130: 1484S-7S.
73. Bouron A., Kiselyov K., Oberwinkler J. Permeation, regulation and control of expression of TRP channels by trace metal ions. Pflugers Arch. Eur. J. Physiol., 2014 (in press).
74. Wagner T. F. J., Drews A., Loch S., Mohr F., Philipp S. E., Lambert S., Oberwinkler J. TRPM3 channels provide a regulated influx pathway for zinc in pancreatic beta cells. Pflugers Arch. Eur. J. Physiol., 2010; 460: 755-65.
75. Chowanadisai W., Lönnerdal B., Kelleher S. L. Identification of a mutation in SLC30A2 (ZnT-2) in women with low milk zinc concentration that results in transient neonatal zinc deficiency. J. Biol. Chem., 2006; 281: 39699-707.
76. Egefjord L., Jensen J. L., Bang-Berthelsen C. H., Petersen A. B., Smidt K., Schmitz O., Karlsen A. E., Pociot F., Chimienti F., et al. Zinc transporter gene expression is regulated by pro-inflammatory cytokines: a potential role for zinc transporters in betacell apoptosis? BMC Endocr. Disord., 2009; 9: 7.
77. Perez-Becerril C., Morris A., Mortimer A., McKenna P. J., de Belleroche J. Allelic variants in the zinc transporter-3 gene, SLC30A3, a candidate gene identified from gene expression studies, show gender-specific association with schizophrenia. Eur. Psychiatry, 2014; 29: 172-8.
78. Da Rocha T. J., Blehm C. J., Bamberg D. P., Fonseca T. L. R., Tisser L. A., De Oliveira Junior A. A., De Andrade F. M., Fiegenbaum M. The effects of interactions between selenium and zinc serum concentration and SEP15 and SLC30A3 gene polymorphisms on memory scores in a population of mature and elderly adults. Genes Nutr., 2014; 9: 377.
79. Zhang X., Liang D., Guo B., Sun L., Chi Z.-H., Cai Y., Wang L., Ma J. Zinc transporter 7 induced by high glucose attenuates epithelial-to-mesenchymal transition of peritoneal mesothelial cells. Biol. Trace Elem. Res., 2013; 151: 138-47.
80. Cauchi S., Del Guerra S., Choquet H., D'Aleo V., Groves C. J., Lupi R., McCarthy M. I., Froguel P., Marchetti P. Meta-analysis and functional effects of the SLC30A8 rs13266634 polymorphism on isolated human pancreatic islets. Mol. Genet. Metab., 2010; 100: 77-82.
81. Kanoni S., Nettleton J. A., Hivert M.-F., Ye Z., van Rooij F. J. A., Shungin D., Sonestedt E., Ngwa J. S., Wojczynski M. K., et al. Total zinc intake may modify the glucose-raising effect of a zinc transporter (SLC30A8) variant: a 14-cohort metaanalysis. Diabetes, 2011; 60: 2407-16.
82. Horikawa Y., Miyake K., Yasuda K., Enya M., Hirota Y., Yamagata K., Hinokio Y., Oka Y., Iwasaki N., et al. Replication of genome-wide association studies of Type 2 diabetes susceptibility in Japan. J. Clin. Endocrinol. Metab., 2008; 93: 3136-41.
83. Ozel A. B., Moroi S. E., Reed D. M., Nika M., Schmidt C. M., Akbari S., Scott K., Rozsa F., Pawar H., et al. Genome-wide association study and meta-analysis of intraocular pressure. Hum. Genet., 2014; 133: 41-57.
84. Jung E. J., Kawai T., Park H. K., Kubo Y., Rokutan K., Arase S. Identification of ultraviolet B-sensitive genes in human peripheral blood cells. J. Med. Invest., 2008; 55: 204-10.
85. Kambe T., Hashimoto A., Fujimoto S. Current understanding of ZIP and ZnT zinc transporters in human health and diseases. Cell Mol. Life Sci., 2014; 71: 3281-95.
86. Fujishiro H., Yoshida M., Nakano Y., Himeno S. Interleukin-6 enhances manganese accumulation in SH-SY5Y cells: implications of the up-regulation of ZIP14 and the down-regulation of ZnT10. Metallomics, 2014; 6: 944-9.
87. Quadri M., Federico A., Zhao T., Breedveld G. J., Battisti C., Delnooz C., Severijnen L. A., Di Toro Mammarella L., Mignarri A., et al. Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am. J. Hum. Genet., 2012; 90: 467-77.
88. Huang L., Tepaamorndech S. The SLC30 family of zinc transporters -A review of current understanding of their biological and pathophysiological roles. Mol. Aspects Med., 2013; 34: 548-60.
89. Baum A. E., Hamshere M., Green E., Cichon S., Rietschel M., Noethen M. M., Craddock N., McMahon F. J. Meta-analysis of two genome-wide association studies of bipolar disorder reveals important points of agreement. Mol. Psychiatry, 2008; 13: 466-7.
90. Schmitt S., Küry S., Giraud M., Dréno B., Kharfi M., Bézieau S. An update on mutations of the SLC39A4 gene in acrodermatitis enteropathica. Hum. Mutat., 2009; 30: 926-33.
91. Guo H., Jin X., Zhu T., Wang T., Tong P., Tian L., Peng Y., Sun L., Wan A., et al. SLC39A5 mutations interfering with the BMP/TGF-ß pathway in non-syndromic high myopia. J. Med. Genet., 2014; 51: 518-25.
92. Wu C., Li D., Jia W., Hu Z., Zhou Y., Yu D., Tong T., Wang M., Lin D., et al. Genome-wide association study identifies common variants in SLC39A6 associated with length of survival in esophageal squamous-cell carcinoma. Nat. Genet., 2013; 45: 632-8.
93. Myers S. A., Nield A., Chew G.-S., Myers M. A. The zinc transporter, slc39a7 (Zip7) is implicated in glycaemic control in skeletal muscle cells. PLoS One, 2013; 8: e79316.
94. Waterworth D. M., Ricketts S. L., Song K., Chen L., Zhao J. H., Ripatti S., Aulchenko Y. S., Zhang W., Yuan X., et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler. Thromb. Vasc. Biol., 2010; 30: 2264-76.
95. Ehret G. B., Munroe P. B., Rice K. M., Bochud M., Johnson A. D., Chasman D. I., Smith A. V., Tobin M. D., Verwoert G. C., et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature, 2011; 478: 103-9.
96. Carrera N., Arrojo M., Sanjuán J., Ramos-Ríos R., Paz E., Suárez-Rama J. J., Páramo M., Agra S., Brenlla J., et al. Association study of nonsynonymous single nucleotide polymorphisms in schizophrenia. Biol. Psychiatry, 2012; 71: 169-77.
97. Pascal L. E., Wang Z. Unzipping Androgen Action Through ZIP9: A Novel Membrane Androgen Receptor. Endocrinology, 2015; 155: 4120-3.
98. Thomas P., Dong J., Berg A. H., Pang Y. Identification and characterization of membrane androgen receptors in the ZIP9 zinc transporter subfamily: II. Role of human ZIP9 in testosterone-induced prostate and breast cancer cell apoptosis. Endocrinology, 2014; 155: 4250-65.
99. Yu Y., Wu A., Zhang Z., Yan G., Zhang F., Zhang L., Shen X., Hu R., Zhang Y., et al. Characterization of the GufA subfamily member SLC39A11/Zip11 as a zinc transporter. J. Nutr. Biochem., 2013; 24: 1697-708.
100. Kelleher S. L., Velasquez V., Croxford T. P., McCormick N. H., Lopez V., MacDavid J. Mapping the zinc-transporting system in mammary cells: molecular analysis reveals a phenotype-dependent zinc-transporting network during lactation. J. Cell Physiol., 2012; 227: 1761-70.
101. Gong J., Hsu L., Harrison T., King I. B., Stürup S., Song X., Duggan D., Liu Y., Hutter C., et al. Genome-wide association study of serum selenium concentrations. Nutrients, 2013; 5: 1706-18.
102. Giunta C., Elçioglu N. H., Albrecht B., Eich G., Chambaz C., Janecke A. R., Yeowell H., Weis M., Eyre D. R., et al. Spondylocheiro Dysplastic Form of the Ehlers-Danlos Syndrome-An Autosomal-Recessive Entity Caused by Mutations in the Zinc Transporter Gene SLC39A13. Am. J. Hum. Genet., 2008; 82: 1290-305.
103. Hershfinkel M. The Zinc-Sensing Receptor, ZnR/GPR39: Signaling and Significance. In: Fukada T., Kambe T., editors. Zinc Signals in Cellular Functions and Disorders. Toyko: Springer; 2014. p. 111-33.
104. Cohen L., Sekler I., Hershfinkel M. The zinc sensing receptor, ZnR/GPR39, controls proliferation and differentiation of colonocytes and thereby tight junction formation in the colon. Cell Death Dis., 2014; 5: e1307.
105. Popovics P., Stewart A. J. GPR39: a Zn(2+)-activated G protein-coupled receptor that regulates pancreatic, gastrointestinal and neuronal functions. Cell Mol. Life Sci., 2011; 68: 85-95.
106. Blindauer C. A. Metallothioneins. In: Maret W., Wedd A., editors. Binding, Transport and Storage of Metal Ions in Biological Cells. Cambridge: Royal Society of Chemistry; 2014. p. 606-65.
107. Colvin R. A., Holmes W. R., Fontaine C. P., Maret W. Cytosolic zinc buffering and muffling: their role in intracellular zinc homeostasis. Metallomics, 2010; 2: 306-17.
108. Maret W. Metals on the move: zinc ions in cellular regulation and in the coordination dynamics of zinc proteins. Biometals, 2011; 24: 411-8.
109. Oteiza P. I. Zinc and the modulation of redox homeostasis. Free Radic. Biol. Med., 2012; 53: 1748-59.
110. Aydemir T. B., Blanchard R. K., Cousins R. J. Zinc supplementation of young men alters metallothionein, zinc transporter, and cytokine gene expression in leukocyte populations. Proc. Natl. Acad. Sci. U S A, 2006; 103: 1699-704.
111. Chu A., Ward S., Zaman K., Foster M., Petocz P., Samman S. Metallothionein (MT-2A) gene expression is upregulated after zinc supplementation in healthy individuals. Proceedings of the Nutrition Society of Australia, 2014; 38: 69.
112. Datta J., Majumder S., Kutay H., Motiwala T., Frankel W., Costa R., Cha H. C., MacDougald O. A., Jacob S. T., Ghoshal K. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein alpha by phosphatidylinositol 3-kinase signaling cascade. Cancer Res., 2007; 67: 2736-46.
113. Foster M., Hancock D., Petocz P., Samman S. Zinc transporter genes are coordinately expressed in men and women independently of dietary or plasma zinc. J. Nutr., 2011; 141: 1195-201.
114. Huber A. M., Gershoff S. N. Effect of zinc deficiency in rats on insulin release from the pancreas. J. Nutr., 1973; 103: 1739-44.
115. Ruz M., Carrasco F., Rojas P., Codoceo J., Inostroza J., Basfi-fer K., Valencia A., Vásquez K., Galgani J., et al. Zinc as a potential coadjuvant in therapy for Type 2 diabetes. Food Nutr. Bull., 2013; 34: 215-21.
116. Capdor J., Foster M., Petocz P., Samman S. Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans. J. Trace Elem. Med. Biol., 2013; 27: 137-42.
117. Foster M., Petocz P., Samman S. Effects of zinc on plasma lipoprotein cholesterol concentrations in humans: a meta-analysis of randomised controlled trials. Atherosclerosis, 2010; 210: 344-52.
118. McCarthy M. I. Genomics, Type 2 diabetes, and obesity. N. Engl. J. Med., 2010; 363: 2339-50.
119. Tamaki M., Fujitani Y., Hara A., Uchida T., Tamura Y., Takeno K., Kawaguchi M., Watanabe T., Ogihara T., et al. The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance. J. Clin. Invest., 2013; 123: 4513-24.
120. Maruthur N. M., Clark J. M., Fu M., Linda Kao W. H., Shuldiner A. R. Effect of zinc supplementation on insulin secretion: interaction between zinc and SLC30A8 genotype in Old Order Amish. Diabetologia, 2014; 58: 295-303.
121. Shan Z., Bao W., Zhang Y., Rong Y., Wang X. Interactions between zinc transporter-8 gene (SLC30A8) and plasma zinc concentrations for impaired glucose regulation and Type 2 diabetes. Diabetes, 2014; 63: 1796-803.
122. Haase H., Maret W. Protein tyrosine phosphatases as targets of the combined insulinomimetic effects of zinc and oxidants. Biometals, 2005; 18: 333-8.
123. Tang X., Shay N. Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and Akt in 3T3-L1 fibroblasts and adipocytes. J. Nutr., 2001; 131: 1414-20.
124. Miranda E. R., Dey C. S. Effect of chromium and zinc on insulin signaling in skeletal muscle cells. Biol. Trace Elem. Res., 2004; 101: 19-36.
125. Marreiro D. D. N., Geloneze B., Tambascia M. A., Lerário A. C., Halpern A., Cozzolino S. M. F. Effect of zinc supplementation on serum leptin levels and insulin resistance of obese women. Biol. Trace Elem. Res., 2006; 112: 109-18.
126. Payahoo L., Ostadrahimi A., Mobasseri M., Bishak Y. K., Jafarabadi M. A. Effects of zinc supplementation on serum leptin level and insulin sensitivity in obese people. Trace Elem. Electrolytes, 2014; 31: 27-33.
127. Hashemipour M., Kelishadi R., Shapouri J., Sarrafzadegan N., Amini M., Tavakoli N., Movahedian-Attar A., Mirmoghtadaee P., Poursafa P. Effect of zinc supplementation on insulin resistance and components of the metabolic syndrome in prepubertal obese children. Hormones (Athens), 2009; 8: 279-85.
128. Kim J., Lee S. Effect of zinc supplementation on insulin resistance and metabolic risk factors in obese Korean women. Nutr. Res. Pract., 2012; 6: 221-5.
129. Seet R. C. S., Lee C.-Y. J., Lim E. C. H., Quek A. M. L., Huang H., Huang S. H., Looi W. F., Long L. H., Halliwell B. Oral zinc supplementation does not improve oxidative stress or vascular function in patients with Type 2 diabetes with normal zinc levels. Atherosclerosis, 2011; 219: 231-9.
130. Oh H.-M., Yoon J.-S. Glycemic control of Type 2 diabetic patients after short-term zinc supplementation. Nutr. Res. Pract., 2008; 2: 283-8.
131. Huang L., Kirschke C. P., Lay Y.-A. E., Levy L. B., Lamirande D. E., Zhang P. H. Znt7-null mice are more susceptible to diet-induced glucose intolerance and insulin resistance. J. Biol. Chem., 2012; 287: 33883-96.
132. Foster M., Chu A., Petocz P., Samman S. Zinc transporter gene expression and glycemic control in post-menopausal women with Type 2 diabetes mellitus. J. Trace Elem. Med. Biol., 2014; 28: 448-52.
133. Foster M., Samman S. Zinc and atherosclerosis: clinical observations and poten-tial mechanisms. In: Rink L, editor. Zinc in Human Health. Amsterdam: IOS Press; 2011. p. 347-72.
134. Malavolta M., Piacenza F., Costarelli L., Giacconi R., Muti E., Cipriano C., Tesei S., Spezia S., Mocchegiani E. Combining UHR-SEC-HPLC-ICP-MS with flow cytometry to quantify metallothioneins and to study zinc homeostasis in human PBMC. J. Anal. At Spectrom., 2007; 22: 1193-8.
135. Wiseman D. A., Wells S. M., Hubbard M., Welker J. E., Black S. M. Alterations in zinc homeostasis underlie endothelial cell death induced by oxidative stress from acute exposure to hydrogen peroxide. Am. J. Physiol. Lung Cell Mol. Physiol., 2007; 292: L165-77.
136. Tubek S. Role of zinc in regulation of arterial blood pressure and in the etiopathogenesis of arterial hypertension. Biol. Trace Elem. Res., 2007; 117: 39-51.
137. Tubek S. Increased absorption of zinc from alimentary tract in primary arterial hypertension. Biol. Trace Elem. Res., 2001; 83: 31-8.
138. Nimmo M., Leggate M., Viana J., King J. The effect of physical activity on mediators of inflammation. Diabetes Obes. Metab., 2013; 15: 51-60.
139. Haase H., Rink L. Functional significance of zinc-related signaling pathways in immune cells. Annu. Rev. Nutr., 2009; 29: 133-52.
140. Stafford S. L., Bokil N. J., Achard M. E. S., Kapetanovic R., Schembri M. A., McEwan A. G., Sweet M. J. Metal ions in macrophage antimicrobial pathways: emerging roles for zinc and copper. Biosci. Rep., 2013; 33: 541-54.
141. Gaetke L. M., McClain C. J., Talwalkar R. T., Shedlofsky S. I. Effects of endotoxin on zinc metabolism in human volunteers. Am. J. Physiol., 1997; 272: E952-6.
142. Besecker B. Y., Exline M. C., Hollyfield J., Phillips G., Disilvestro R. A., Wewers M. D., Knoell D. L. A comparison of zinc metabolism , inflammation , and disease severity in critically ill infected and noninfected adults early after intensive care. Am. J. Clin. Nutr., 2011; 93: 1356-64.
143. Liuzzi J. P., Lichten L. A., Rivera S., Blanchard R. K., Aydemir T. B., Knutson M. D., Ganz T., Cousins R. J. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc. Natl. Acad. Sci. U S A, 2005; 102: 6843-8.
144. Liu M.-J., Bao S., Gálvez-Peralta M., Pyle C. J., Rudawsky A. C., Pavlovicz R. E., Killilea D. W., Li C., Nebert D. W., et al. ZIP8 regulates host defense through zincmediated inhibition of NF-κB. Cell Rep., 2013; 3: 386-400.
145. Summersgill H., England H., Lopez-Castejon G., Lawrence C. B., Luheshi N. M., Pahle J., Mendes P., Brough D. Zinc depletion regulates the processing and secretion of IL-1ß. Cell Death Dis., 2014; 5: e1040.
146. Chu A., Foster M., Hancock D., Bell-Anderson K., Petocz P., Samman S. TNF-a gene expression is increased following zinc supplementation in Type 2 diabetes mellitus. Genes Nutr., 2015; 10: 440.
147. Foster M., Petocz P., Samman S. Inflammation markers predict zinc transporter gene expression in women with Type 2 diabetes mellitus. J. Nutr. Biochem., 2013; 24: 1655-61.
148. Chu A., Samman S. Zinc Homeostasis in Exercise: Implications for Physical Performance. Vitam. Miner., 2014; 3: 40-2.
149. DeRuisseau K. C., Cheuvront S. N., Hyames E. M., Sharp R. G. Sweat iron and zinc losses during prolonged exercise. Int. J. Sport Nutr., 2002; 12: 428-37.
150. Hoshi A., Watanabe H., Chiba M., Inaba Y., Kobayashi M., Kimura N., Ito T. Seasonal variation of trace element loss to sweat during exercise in males. Environ. Health Prev. Med., 2002; 7: 60-3.
151. Montain S. J., Cheuvront S. N., Lukaski H. C. Sweat mineral-element responses during 7 h of exercise-heat stress. Int. J. Sport Nutr. Exerc. Metab., 2007; 17: 574-82.
152. Anderson R. A., Polansky M. M., Bryden N. A. Strenuous running -Acute effects of chromium, copper, zinc and selected clinical variables in urine and serum of male runners. Biol. Trace Elem. Res., 1984; 6: 327-36.
153. Anderson R. A., Bryden N. A., Polansky M. M., Deuster P. A. Acute exercise effects on urinary losses and serum concentrations of copper and zinc of moderately trained and untrained men consuming a controlled diet. Analyst, 1995; 120: 867-70.
154. Lukaski H. C., Bolonchuk W. W., Klevay L. M., Milne D. B., Sandstead H. H. Changes in plasma zinc content after exercise in men fed a low-zinc diet. Am. J. Physiol. -Endocrinol. Metab., 1984; 247: E88-93.
155. Kaczmarski M., Wójcicki J., Samochowiec L., Dutkiewicz T., Sych Z. The influence of exogenous antioxidants and physical exercise on some parameters associated with production and removal of free radicals. Pharmazie, 1999; 54: 303-6.
156. Bordin D., Sartorelli L., Bonanni G., Mastrogiacomo I., Scalco E. High intensity physical exercise induced effects on plasma levels of copper and zinc. Biol. Trace Elem. Res., 1993; 36: 129-34.
157. Ohno H., Hirata F., Terayama K., Kawarabayashi T., Doi R., Kondo T., Taniguchi N. Effect of short physical exercise on the levels of zinc and carbonic anhydrase isoenzyme activities in human erythrocytes. Eur. J. Appl. Physiol., 1983; 51: 257-68.
158. Gleeson M., Almey J., Brooks S., Cave R., Lewis A., Griffiths H. Haematological and acute-phase responses associated with delayed-onset muscle soreness in humans. Eur. J. Appl. Physiol. Occup. Physiol., 1995; 71: 137-42.
159. Döker S., Hazar M., Uslu M., Okan I., Kafkas E., Bosgelmez I. I. Influence of training frequency on serum concentrations of some essential trace elements and electrolytes in male swimmers. Biol. Trace Elem. Res., 2014; 158: 15-21.
160. Karakukcu C., Polat Y., Torun Y. A., Pac A. K. The effects of acute and regular exercise on calcium, phosphorus and trace elements in young amateur boxers. Clin. Lab., 2013; 59: 557-562.
161. Volpe S. L., Lowe N. M., Woodhouse L. R., King J. C. Effect of maximal exercise on the short-term kinetics of zinc metabolism in sedentary men. Br. J. Sports Med., 2007; 41: 156-61.
162. Kara E., Akil M., Yalçinkaya ö. The effect of aerobic exercise programme on trace element levels of young men. African J. Microbiol. Res., 2012; 6: 165-8.
163. Ohno H., Sato Y., Ishikawa M., Yahata T., Gasa S., Doi R., Yamamura K., Taniguchi N. Training effects on blood zinc levels in humans. J. Sports Med. Phys. Fitness, 1990; 30: 247-53.
164. Peake J. M., Gerrard D. F., Griffin J. F. T. Plasma zinc and immune markers in runners in response to a moderate increase in training volume. Int. J. Sports Med., 2003; 24: 212-6.
165. Couzy F., Lafargue P., Guezennec C. Y. Zinc metabolism in the athlete: influence of training, nutrition and other factors. Int. J. Sports Med., 1990; 11: 263-6.
166. Córdova A., Navas F. J. Effect of training on zinc metabolism: changes in serum and sweat zinc concentrations in sportsmen. Ann. Nutr. Metab., 1998; 42: 274-82.
167. Koury J., de Oliveira A., Portella E. S., de Oliveira C. F., Lopes G. C., Donangelo C. M. Zinc and copper biochemical indices of antioxidant status in elite athletes of different modalities. Int. J. Sport Nutr. Exerc. Metab., 2004; 14: 358-72.
168. Sprouse C., Gordish-Dressman H., Orkunoglu-Suer E. F., Lipof J. S., Moeckel-Cole S., Patel R. R., Adham K., Larkin J. S., Hubal M. J., et al. SLC30A8 nonsynonymous variant is associated with recovery following exercise and skeletal muscle size and strength. Diabetes, 2014; 63: 363-8.